AbbVie, Inc. (ABBV)
262.82
+2.89
(+1.11%)
USD |
NYSE |
Oct 02, 16:00
263.85
+1.03
(+0.39%)
After-Hours: 20:00
AbbVie Price : 262.82 for Oct. 2, 2026
Price Chart
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 02, 2026 | 259.74 | 264.06 | 257.87 | 262.82 | 5.863M |
| Oct 01, 2026 | 260.51 | 262.32 | 259.00 | 259.93 | 3.892M |
| Sep 30, 2026 | 264.60 | 265.36 | 261.59 | 261.59 | 4.389M |
| Sep 29, 2026 | 265.45 | 268.93 | 261.52 | 263.29 | 4.004M |
| Sep 28, 2026 | 264.33 | 267.74 | 263.38 | 266.28 | 4.430M |
| Sep 25, 2026 | 265.49 | 266.00 | 262.59 | 264.34 | 2.542M |
| Sep 24, 2026 | 265.37 | 267.41 | 263.09 | 265.12 | 3.458M |
| Sep 23, 2026 | 266.00 | 269.39 | 263.59 | 265.08 | 3.469M |
| Sep 22, 2026 | 263.10 | 266.82 | 262.14 | 265.21 | 2.766M |
| Sep 21, 2026 | 263.07 | 266.60 | 261.23 | 264.48 | 3.438M |
| Sep 18, 2026 | 263.29 | 266.34 | 262.44 | 263.96 | 8.177M |
| Sep 17, 2026 | 262.61 | 264.62 | 260.88 | 264.02 | 3.510M |
| Sep 16, 2026 | 261.99 | 264.00 | 260.98 | 262.51 | 3.118M |
| Sep 15, 2026 | 260.00 | 264.81 | 257.80 | 263.04 | 5.120M |
| Sep 14, 2026 | 261.67 | 264.65 | 260.10 | 261.77 | 4.512M |
| Sep 11, 2026 | 253.92 | 259.61 | 253.92 | 257.12 | 4.309M |
| Sep 10, 2026 | 251.23 | 255.31 | 249.74 | 255.00 | 4.398M |
| Sep 09, 2026 | 247.73 | 251.18 | 246.77 | 250.91 | 3.867M |
| Sep 08, 2026 | 251.84 | 254.62 | 248.41 | 248.78 | 5.572M |
| Sep 04, 2026 | 257.96 | 258.91 | 255.58 | 256.46 | 4.730M |
| Sep 03, 2026 | 264.00 | 264.25 | 257.14 | 260.21 | 2.879M |
| Sep 02, 2026 | 262.70 | 262.97 | 257.70 | 261.72 | 4.226M |
| Sep 01, 2026 | 260.99 | 262.26 | 257.79 | 259.99 | 3.867M |
| Aug 31, 2026 | 254.17 | 258.24 | 252.33 | 256.42 | 4.315M |
| Aug 28, 2026 | 258.67 | 259.00 | 255.08 | 255.48 | 3.225M |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| Biogen, Inc. | 219.88 |
| Gilead Sciences, Inc. | 144.74 |
| Amgen, Inc. | 403.04 |
| Regeneron Pharmaceuticals, Inc. | 735.20 |
| Johnson & Johnson | 256.03 |
Price Related Metrics
| PE Ratio | 74.31 |
| PS Ratio | 7.236 |
| PEG Ratio | 1.088 |
| Price to Free Cash Flow | 25.59 |
| Earnings Yield | 1.35% |
| Market Cap | 464.42B |
| PEGY Ratio | 1.048 |
| Operating PE Ratio | 21.17 |
| Normalized PE Ratio | 32.64 |